Home » Topics » BioWorld Science

BioWorld Science
RSS

Chaperone gene therapy delays ALS

July 8, 2019

New target improves metabolism

July 8, 2019

Rare frameshift mutation in SERPINA3 associated with generalized pustular psoriasis

July 8, 2019

CXCL10 gene promoter -1447A>G polymorphism as a new biomarker of susceptibility to malaria

July 8, 2019

Novel PIK3CD gene variant linked to activated PI3Kdelta syndrome

July 8, 2019

Tau-targeted PET with flortaucipir in Alzheimer's disease: evaluation of tau and cognitive changes

July 8, 2019

Antimicrobial peptide LL-37 shows promising efficacy against S. aureus biofilms

July 8, 2019

PK and safety of a new formulation of nemiralisib inhaled as dry powder in healthy individuals

July 8, 2019

Syndecan-2 increases cell invasiveness in lung adenocarcinoma

July 8, 2019

EMA validates clinical development program for AB-8939

July 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...